![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Wollenberg, Andreas; Lio, Peter; Kleyn, Elise; Bissonnette, Robert; Rueda, Maria Jose; Casillas, Marta; Chen, Yun-Fei; Lu, Na; Schloebe, Andrea und Simpson, Eric
(2022):
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials.
In: European Journal of Dermatology, Bd. 32, Nr. 4: S. 522-529
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Agner, Tove; Bissonnette, Robert; Cohen, David E.; Simpson, Eric; Wollenberg, Andreas und Thyssen, Jacob P.
(2021):
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.
In: Dermatitis, Bd. 32, Nr. 5: S. 319-326
Silverberg, Jonathan I.; Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Kabashima, Kenji; DeLozier, Amy M.; Sun, Luna; Cardillo, Tracy; Nunes, Fabio P. und Reich, Kristian
(2021):
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders An Extension Study of 2 Randomized Clinical Trials.
In: Jama Dermatology, Bd. 157, Nr. 6: S. 691-699
Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Silverberg, Jonathan I.; Papacharalambous, Jocelyne; Zhu, Linda; Zhang, Weidong; Beebe, Jean S.; Vincent, Michael; Peeva, Elena; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Chen, Linda; Sikirica, Vanja und Xenakis, Jason
(2021):
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.
In: Dermatitis, Bd. 32, Nr. 1S:
S53-S61
Guttman-Yassky, Emma; Hanifin, Jon M.; Boguniewicz, Mark; Wollenberg, Andreas; Bissonnette, Robert; Purohit, Vivek; Kilty, Iain; Tallman, Anna M. und Zielinski, Michael A.
(2019):
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
In: Experimental Dermatology, Bd. 28, Nr. 1: S. 3-10
Vender, Ron; Gordon, Kenneth B.; Duffin, Kristina Callis; Bissonnette, Robert; Prinz, Jörg C.; Han, Chenglong; Wasfi, Yasmine; Shen, Yaung-Kaung; Randazzo, Bruce und Reich, Kristian
(2016):
Comparison of guselkumab with placebo and adalimumab on health-related quality of life in a phase 2b clinical trial X-PLORE.
In: Journal of the American Academy of Dermatology, Bd. 74, Nr. 5:
AB241-AB241